No Brexit worry for St James's Oncology ratings
UK hospital funding vehicle St James's Oncology Finance demonstrated last week how easy it can be to shrug off Brexit risks to an issuer’s ratings, despite political rhetoric ramping up since UK prime minister Theresa May triggered Article 50.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts